Previous studies identified that patients experiencing MC trended toward exposure to a single agent PD-L1 compared to individuals developing classical acute colitis, although this did not reach statistical significance. 7 Additional factors that may predispose individuals to developing a MC in response to ICI therapy include the relatively low percentage of current and former smokers in our population.
← all excerpts
Clinical Course and Impact of Immune Checkpoint Inhibitor Colitis Resembling Microscopic Colitis.
1
—
—